Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 04/6/18 → 04/6/22 |
Funding
- Ra Pharmaceuticals Incorporated: $55,641.00
A Phase 2, Multicenter, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of RA101495 in Subjects with Generalized Myasthenia Gravis
- Wolfe, Gil (PI)
- Silvestri, Nicholas (CoI)
Project: Research